Printer Friendly

ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES APPOINTMENT OF CHIEF OPERATING OFFICER

 ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES
 APPOINTMENT OF CHIEF OPERATING OFFICER
 EATONTOWN, N.J., Sept. 3 /PRNewswire/ -- Roberts Pharmaceutical Corporation (NASDAQ: RPCX) today announced the appointment of Robert W. Loy as chief operating officer. In his new position, Loy will assume day-to-day control over six functional areas including sales and marketing, pharmaceutics, manufacturing operations, research and development, regulatory affairs and the company's Canadian subsidiary.
 Loy joins Roberts with almost 30 years of pharmaceutical industry experience. Most recently he held the position of vice president, international sales and marketing with Hollister, Inc. and for 27 years prior to that, held various senior level positions throughout the Squibb Corporation including most notably, vice president, worldwide operations for the Squibb Derm Division in Skillman, N.J.
 Commenting on the appointment, Dr. Robert A. Vukovich, chairman and CEO, said, "Mr. Loy's many years of industry experience and leadership qualities will augment a very talented and dedicated team of professionals. Under his leadership, we will continue to grow and more fully realize our corporate growth objectives."
 Loy is a graduate of Old Dominion University and attended Villanova University Graduate School. He and his family are planning to relocate from Illinois to New Jersey in the near future.
 Roberts Pharmaceuticals is an established pharmaceutical company specializing in prescription drug products which are currently marketed in seven countries with operating subsidiary companies in the United States, Canada, and the United Kingdom. Roberts has seven drugs in late stage clinical development and currently markets over 80 different products for urological therapy, pain management, cough/cold, gastrointestinal disease, endocrine disorders and dermatological conditions.
 -0- 9/3/92
 /CONTACT: Anthony P. Maris of Roberts Pharmaceuticals, 908-389-1182/
 (RPCX) CO: Roberts Pharmaceutical Corporation ST: New Jersey IN: MTC SU: PER


CK-OS -- NY057 -- 6408 09/03/92 12:08 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 3, 1992
Words:295
Previous Article:ONASCO COMPANIES, INC. ANNOUNCES A REVERSE STOCK SPLIT
Next Article:TOM GALLAGHER ELECTED CHRYSLER VICE PRESIDENT
Topics:


Related Articles
ICN AND SUBSIDIARY COMPANIES ANNOUNCE MANAGEMENT APPOINTMENTS
ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES APPOINTMENT OF CHIEF OPERATING OFFICER
ROBERTS PHARMACEUTICAL CORPORATION ELECTS NEW DIRECTOR
ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES APPOINTMENT OF NEW GENERAL MANAGER OF CANADIAN SUBSIDIARY
ROBERTS PHARMACEUTICAL CORPORATION ELECTS TWO NEW DIRECTORS
ROBERTS PHARMACEUTICAL CORPORATION EXPANDS EUROPEAN OPERATIONS BY ESTABLISHMENT OF FRENCH SUBSIDIARY - APPOINTS MANAGING DIRECTOR
JACQUES F. REJEANGE NAMED PRESIDENT AND CHIEF OPERATING OFFICER OF STERLING WINTHROP INC.; APPOINTMENT SIGNALS COMPANY POISED FOR GROWTH
ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES THE APPOINTMENT OF NEW CHIEF FINANCIAL OFFICER
ROBERTS PHARMACEUTICAL CORPORATION CREATES THE POSITION OF WORLDWIDE SALES AND MARKETING AND ANNOUNCES MANAGEMENT ADDITIONS
Roberts Pharmaceutical Corporation Announces Decision of Its Founder to Retire.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters